Intersect Capital’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$582K Buy
4,376
+1,496
+52% +$204K 0.18% 119
2022
Q1
$394K Buy
2,880
+331
+13% +$46.1K 0.08% 245
2021
Q4
$441K Buy
+2,549
New +$388K 0.08% 223
2015
Q2
Sell
-70
Closed -$5K 175
2015
Q1
$5K Hold
70
﹤0.01% 371
2014
Q4
$5K Buy
+70
New +$4.42K ﹤0.01% 388

Other funds holding DGX

Intersect Capital's DGX Position: Q2 2022 in Review

Intersect Capital increased its Quest Diagnostics (DGX) stake by 52% in Q2 2022, buying an estimated $204K and bringing the position to 4,376 shares worth $582K. The position accounts for 0.18% of the portfolio, ranked #119.

Intersect Capital first reported a position in DGX in Q4 2014 and has held it in 5 quarters since. 850 funds tracked by Wall St. Rank hold DGX as of Q2 2022.

  • Intersect Capital held 4,376 shares of Quest Diagnostics worth $582K as of Q2 2022.
  • Intersect Capital bought 1,496 Quest Diagnostics shares in Q2 2022, an estimated $204K.
  • Quest Diagnostics made up 0.18% of Intersect Capital's portfolio in Q2 2022, its #119 holding.
  • Intersect Capital first reported a position in Quest Diagnostics in Q4 2014 and has held it in 5 quarters since.
  • 850 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.

Based on Intersect Capital's 13F filing for Q2 2022, filed 2 Sep 2022.